IL17A and neoplasm: The upregulation of IL-17 may stimulate VEGF-dependent angiogenesis (35), induce neutrophil recruitment, and employ other mechanisms to promote tumorigenesis, mobilization of pathological myeloid-derived suppressor cells(PMN-MDSCs) (36) and directly activates tumor cells through the PI3K/AKT signaling pathway (37).